CoChat
Sign Up
Cited by 58

New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project

Tal, Tamara, Myhre, Oddvar, Fritsche, Ellen, Rüegg, Joëlle, Craenen, Kai, Aiello-Holden, Kiara, Agrillo, Caroline, Babin, Patrick J. +26 more·2024·Frontiers in Toxicology
DOI 10.3389/ftox.2024.1359507PMC PMC11089904
Open this paper in CoChat — free account

Abstract

In the European regulatory context, rodent in vivo studies are the predominant source of neurotoxicity information. Although they form a cornerstone of neurotoxicological assessments, they are costly and the topic of ethical debate. While the public expects chemicals and products to be safe for the developing and mature nervous systems, considerable numbers of chemicals in commerce have not, or only to a limited extent, been assessed for their potential to cause neurotoxicity. As such, there is a societal push toward the replacement of animal models with in vitro or alternative methods. New approach methods (NAMs) can contribute to the regulatory knowledge base, increase chemical safety, and modernize chemical hazard and risk assessment. Provided they reach an acceptable level of regulatory relevance and reliability, NAMs may be considered as replacements for specific in vivo studies. The European Partnership for the Assessment of Risks from Chemicals (PARC) addresses challenges to the development and implementation of NAMs in chemical risk assessment. In collaboration with regulatory agencies, Project 5.2.1e (Neurotoxicity) aims to develop and evaluate NAMs for developmental neurotoxicity (DNT) and adult neurotoxicity (ANT) and to understand the applicability domain of specific NAMs for the detection of endocrine disruption and epigenetic perturbation. To speed up assay time and reduce costs, we identify early indicators of later-onset effects. Ultimately, we will assemble second-generation developmental neurotoxicity and first-generation adult neurotoxicity test batteries, both of which aim to provide regulatory hazard and risk assessors and industry stakeholders with robust, speedy, lower-cost, and informative next-generation hazard and risk assessment tools.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/ftox.2024.1359507

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 140

  1. Ankley G. T. Bennett R. S. Erickson R. J. Hoff D. J. Hornung M. W. Johnson R. D. (2010). Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29 (3), 730– 741. 10.1002/ETC.34 20821501 · DOI · Paper page
  2. Apicella L. Fabbretti E. (2012). P2X3 receptor expression by HEK cells conditions their survival. Purinergic Signal. 8 (2), 295– 300. 10.1007/S11302-011-9285-0 22160848 PMC3350583 · DOI
  3. Aung M. T. Eick S. M. Padula A. M. Smith S. Park J. S. DeMicco E. (2023). Maternal per- and poly-fluoroalkyl substances exposures associated with higher depressive symptom scores among immigrant women in the chemicals in our bodies cohort in san francisco. Environ. Int. 172 (February), 107758. 10.1016/J.ENVINT.2023.107758 36682206 PMC10840585 · DOI
  4. Babin P. J. Goizet C. Raldúa D. (2014). Zebrafish models of human motor neuron diseases: advantages and limitations. Prog. Neurobiol. 118, 36– 58. 10.1016/J.PNEUROBIO.2014.03.001 24705136 · DOI
  5. Baccarelli A. Bollati V. (2009). Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 21 (2), 243– 251. 10.1097/MOP.0B013E32832925CC 19663042 PMC3035853 · DOI
  6. Bal-Price A. Hogberg H. T. Crofton K. M. Daneshian M. FitzGerald R. E. Fritsche E. (2018). Recommendation on test readiness criteria for new approach methods in Toxicology: exemplified for developmental neurotoxicity. Altex 35 (3), 306– 352. 10.14573/altex.1712081 29485663 PMC6545888 · DOI
  7. Banks W. A. (2009). Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9 (Suppl. 1), S3– S9. 10.1186/1471-2377-9-S1-S3 19534732 PMC2697631 · DOI · Paper page
  8. Bartmann K. Bendt F. Dönmez A. Haag D. Eike Keßel H. Masjosthusmann S. (2023). A human IPSC-based in vitro neural network formation assay to investigate neurodevelopmental toxicity of pesticides. ALTEX - Altern. Animal Exp. 40, 452– 470. 10.14573/ALTEX.2206031 37158368 · DOI · Paper page
  9. Baumann J. Barenys M. Gassmann K. Fritsche E. (2014). Comparative human and rat ‘neurosphere assay’ for developmental neurotoxicity testing. Curr. Protoc. Toxicol. 1 (Suppl. 59), 12– 24. 10.1002/0471140856.TX1221S59 24898107 · DOI
  10. Baumann J. Dach K. Barenys M. Giersiefer S. Goniwiecha J. Lein P. J. (2015). “ Application of the neurosphere assay for DNT hazard assessment: challenges and limitations,” in Methods in pharmacology and Toxicology (Totowa, NJ: Humana Press), 29. 10.1007/7653_2015_49 · DOI
  11. Baumann J. Gassmann K. Masjosthusmann S. DeBoer D. Bendt F. Giersiefer S. (2016). Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Archives Toxicol. 90 (6), 1415– 1427. 10.1007/S00204-015-1568-8 26216354 · DOI · Paper page
  12. Bellanger M. Demeneix B. Grandjean P. Thomas Zoeller R. Trasande L. (2015). Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European union. J. Clin. Endocrinol. Metabolism 100 (4), 1256– 1266. 10.1210/JC.2014-4323 PMC4399309 25742515 · DOI
  13. Bellanger M. Pichery C. Aerts D. Berglund M. Castaño A. Čejchanová M. (2013). Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention. Environ. Health A Glob. Access Sci. Source 12 (1), 3– 10. 10.1186/1476-069x-12-3 PMC3599906 23289875 · DOI
  14. Bennett D. Bellinger D. C. Birnbaum L. S. Bradman A. Chen A. Cory-Slechta D. A. (2016). Project TENDR: targeting environmental neuro-developmental risks the TENDR consensus statement. Environ. Health Perspect. 124 (7), A118– A122. 10.1289/EHP358 27479987 PMC4937840 · DOI · Paper page
  15. Bernal J. Guadaño-Ferraz A. Morte B. (2015). Thyroid hormone transporters--functions and clinical implications. Nat. Rev. Endocrinol. 11 (7), 690– 717. 10.1038/nrendo.2015.186 26485690 · DOI · Paper page
  16. Braunbeck T. Kais B. Lammer E. Otte J. Schneider K. Stengel D. (2014). The fish embryo test (FET): origin, applications, and future. Environ. Sci. Pollut. Res. 22 (21), 16247– 16261. 10.1007/S11356-014-3814-7 25395325 · DOI
  17. Brown J. P. Hall D. Frank C. L. Wallace K. Mundy W. R. Shafer T. J. (2016). Editor's highlight: evaluation of a microelectrode array-based assay for neural network ontogeny using training set chemicals. Toxicol. Sci. 154 (1), 126– 139. 10.1093/toxsci/kfw147 27492221 · DOI
  18. Brüll M. Spreng A.-S. Gutbier S. Loser D. Krebs A. Reich M. (2020). Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies. ALTEX - Altern. Animal Exp. 37 (3), 409– 428. 10.14573/ALTEX.1911111 32150624 · DOI
  19. Bruni G. Rennekamp A. J. Velenich A. McCarroll M. Gendelev L. Fertsch E. (2016). Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat. Chem. Biol. 12 (7), 559– 566. 10.1038/nchembio.2097 27239787 PMC4912417 · DOI
  20. Chesnut M. Paschoud H. Repond C. Smirnova L. Hartung T. Zurich M.-G. (2021). Human IPSC-derived model to study myelin disruption. Int. J. Mol. Sci. 22 (17), 9473. 10.3390/IJMS22179473 34502381 PMC8430601 · DOI
  21. Chu J. Sadler K. C. (2009). New school in liver development: lessons from zebrafish. Hepatology 50 (5), 1656– 1663. 10.1002/HEP.23157 19693947 PMC3093159 · DOI
  22. Costa L. G. Aschner M. Vitalone A. Syversen T. Soldin O. P. (2004). Developmental neuropathology of environmental agents. Annu. Rev. Pharmacol. Toxicol. 44, 87– 110. 10.1146/annurev.pharmtox.44.101802.121424 14744240 PMC3625636 · DOI
  23. Costa L. G. Giordano G. Guizzetti M. Vitalone A. (2008). Neurotoxicity of pesticides: a brief review. Front. Biosci. 13 (4), 1240– 1249. 10.2741/2758 17981626 · DOI
  24. Craig E. Kelly L. Akerman G. Dawson J. May B. Reaves E. (2019). Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: lessons from the EPA office of pesticide programs’ hazard and science policy Council. Regul. Toxicol. Pharmacol. RTP 108 (November), 104481. 10.1016/J.YRTPH.2019.104481 31546018 PMC7232786 · DOI
  25. Crofton K. M. Mundy W. R. (2021). External scientific report on the interpretation of data from the developmental neurotoxicity in vitro testing assays for use in integrated approaches for testing and assessment. EFSA Support. Publ. 18 (10). 10.2903/SP.EFSA.2021.EN-6924 · DOI
  26. Crofton K. M. Mundy W. R. Shafer T. J. (2012). Developmental neurotoxicity testing: a path forward. Congenit. Anomalies. Congenit. Anom. (Kyoto) 52, 140– 146. 10.1111/j.1741-4520.2012.00377.x 22925214 · DOI
  27. Dach K. Bendt F. Huebenthal U. Giersiefer S. Lein P. J. Heuer H. (2017). BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action. Sci. Rep. 7 (44861), 44861. 10.1038/srep44861 28317842 PMC5357893 · DOI
  28. Davidsen N. Lauvås A. J. Myhre O. Ropstad E. Carpi D. Gyves E. M. de (2021). Exposure to human relevant mixtures of halogenated persistent organic pollutants (POPs) alters neurodevelopmental processes in human neural stem cells undergoing differentiation. Reprod. Toxicol. 100 (April 2020), 17– 34. 10.1016/j.reprotox.2020.12.013 33333158 PMC7992035 · DOI
  29. Delp J. Cediel-Ulloa A. Suciu I. Kranaster P. Vugt-Lussenburg B.Ma V. Munic Kos V. (2021). Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Archives Toxicol. 95, 591– 615. 10.1007/s00204-020-02970-5 PMC7870626 33512557 · DOI
  30. Delp J. Funke M. Rudolf F. Cediel A. Bennekou S. H. van der Stel W. (2019). Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants. Archives Toxicol. 93 (6), 1585– 1608. 10.1007/S00204-019-02473-Y 31190196 · DOI
  31. Dickerson A. S. Wu A. C. Liew Z. Weisskopf M. (2020). A scoping review of non-occupational exposures to environmental pollutants and adult depression, anxiety, and suicide. Curr. Environ. Health Rep. 7 (3), 256– 271. 10.1007/s40572-020-00280-7 32533365 PMC7483936 · DOI
  32. Druwe I. Freudenrich T. M. Wallace K. Shafer T. J. Mundy W. R. (2015). Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening. Toxicology 333 (July), 14– 24. 10.1016/J.TOX.2015.03.011 25841707 · DOI
  33. Duboc V. Dufourcq P. Blader P. Roussigné M. (2015). Asymmetry of the brain: development and implications. Annu. Rev. Genet. 49, 647– 672. 10.1146/ANNUREV-GENET-112414-055322 26442849 · DOI
  34. Dubrana L. E. Knoll-Gellida A. Bourcier L. M. Mercé T. Pedemay S. Nachon F. (2021). An antidote screening system for organophosphorus poisoning using zebrafish larvae. ACS Chem. Neurosci. 12 (15), 2865– 2877. 10.1021/ACSCHEMNEURO.1C00251 34284583 · DOI
  35. ECHA (2023). Key areas of regulatory challenge. Eur. Chem. Agency. ECHA-23-R- (ED-07-23-212-EN-N). 10.2823/568850 · DOI
  36. EFSA Scientific Committee Hardy A. Benford D. Halldorsson T. Jeger M. J. Katrine Knutsen H. More S. (2017). Guidance on the risk assessment of substances present in food intended for infants below 16 Weeks of age. EFSA J. 15 (5), e04849. 10.2903/J.EFSA.2017.4849 32625502 PMC7010120 · DOI
  37. Eriksson P. S. Perfilieva E. Björk-Eriksson T. Alborn A. M. Nordborg C. Peterson D. A. (1998). Neurogenesis in the adult human Hippocampus. Nat. Med. 4 (11), 1313– 1317. 10.1038/3305 9809557 · DOI · Paper page
  38. Escher B. I. Altenburger R. Blüher M. Colbourne J. K. Ebinghaus R. Fantke P. (2023). Modernizing persistence-bioaccumulation-toxicity (PBT) assessment with high throughput animal-free methods. Archives Toxicol. 97 (5), 1267– 1283. 10.1007/S00204-023-03485-5 PMC10110678 36952002 · DOI
  39. Faria M. Garcia-Reyero N. Padrós F. Babin P. J. Sebastián D. Cachot J. (2015). Zebrafish models for human acute organophosphorus poisoning. Sci. Rep. 5 (October), 15591. 10.1038/SREP15591 26489395 PMC4614985 · DOI
  40. Frank C. L. Brown J. P. Wallace K. Mundy W. R. Shafer T. J. (2017). From the cover: developmental neurotoxicants disrupt activity in cortical networks on microelectrode arrays: results of screening 86 compounds during neural network formation. Toxicol. Sci. 160 (1), 121– 135. 10.1093/toxsci/kfx169 28973552 · DOI
  41. Fritsche E. (2017). “ Report on integrated testing strategies for the identification and evaluation of chemical hazards associated with the developmental neurotoxicity (DNT), to facilitate discussions at the Joint EFSA/OECD workshop on DNT.” ENV/JM/MONO(2017)4/ANN1.
  42. Fritsche E. Grandjean P. Crofton K. M. Aschner M. Goldberg A. Heinonen T. (2018). Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. Toxicol. Appl. Pharmacol. 354 (September), 3– 6. 10.1016/J.TAAP.2018.02.004 29447839 PMC6097873 · DOI · Paper page
  43. Gadaleta D. Spînu N. Roncaglioni A. Cronin M. T. D. Benfenati E. (2022). Prediction of the neurotoxic potential of chemicals based on modelling of molecular initiating events upstream of the adverse outcome pathways of (developmental) neurotoxicity. Int. J. Mol. Sci. 23 (6), 3053. 10.3390/ijms23063053 35328472 PMC8954925 · DOI
  44. Giordano G. Costa L. G. (2012). Developmental neurotoxicity: some old and new issues. ISRN Toxicol. 2012 (June), 814795– 814812. 10.5402/2012/814795 23724296 PMC3658697 · DOI
  45. Glaberman S. Padilla S. Barron M. G. (2017). Evaluating the zebrafish embryo toxicity test for pesticide hazard screening. Environ. Toxicol. Chem. 36 (5), 1221– 1226. 10.1002/ETC.3641 27699829 PMC7737843 · DOI
  46. Grandjean P. Landrigan P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368 (9553), 2167– 2178. 10.1016/S0140-6736(06)69665-7 17174709 · DOI · Paper page
  47. Grandjean P. Landrigan P. J. (2014). Neurobehavioural effects of developmental toxicity. Lancet Neurology 13 (3), 330– 338. 10.1016/S1474-4422(13)70278-3 24556010 PMC4418502 · DOI · Paper page
  48. Grillberger K. Cöllen E. Immacolata Trivisani C. Blum J. Leist M. Ecker G. F. (2023). Structural insights into neonicotinoids and N-unsubstituted metabolites on human NAChRs by molecular docking, dynamics simulations, and calcium imaging. Int. J. Mol. Sci. 24 (17), 13170. 10.3390/IJMS241713170 37685977 PMC10487998 · DOI
  49. Gunnarsson L. Jauhiainen A. Kristiansson E. Nerman O. Joakim Larsson D. G. (2008). Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 42 (15), 5807– 5813. 10.1021/es8005173 18754513 · DOI
  50. Gupta T. Marquart G. D. Horstick E. J. Tabor K. M. Pajevic S. Burgess H. A. (2018). Morphometric analysis and neuroanatomical mapping of the zebrafish brain. Methods 150 (November), 49– 62. 10.1016/J.YMETH.2018.06.008 29936090 PMC6296225 · DOI
  51. Gutbier S. Spreng A. S. Delp J. Schildknecht S. Karreman C. Suciu I. (2018). Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress. Cell Death Differ. 25 (12), 2101– 2117. 10.1038/S41418-018-0229-X 30390092 PMC6261954 · DOI
  52. Harrill J. A. Freudenrich T. M. Machacek D. W. Stice S. L. Mundy W. R. (2010). Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived HN2 cells using automated high-content image analysis. Neurotoxicology 31 (3), 277– 290. 10.1016/J.NEURO.2010.02.003 20188755 · DOI
  53. Harrill J. A. Robinette B. L. Freudenrich T. Mundy W. R. (2013). Use of high content image analyses to detect chemical-mediated effects on neurite sub-populations in primary rat cortical neurons. NeuroToxicology 34 (1), 61– 73. 10.1016/J.NEURO.2012.10.013 23142577 · DOI
  54. Harrill J. A. Robinette B. L. Mundy W. R. (2011). Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol. Vitro 25 (1), 368– 387. 10.1016/j.tiv.2010.10.011 20969947 · DOI
  55. Harry G. J. McBride S. Witchey S. K. Mhaouty-Kodja S. Trembleau A. Bridge M. (2022). Roadbumps at the crossroads of integrating behavioral and in vitro approaches for neurotoxicity assessment. Front. Toxicol. 4, 812863. 10.3389/FTOX.2022.812863 35295216 PMC8915899 · DOI
  56. Hartmann J. Henschel N. Bartmann K. Dönmez A. Brockerhoff G. Koch K. (2023). Molecular and functional characterization of different BrainSphere models for use in neurotoxicity testing on microelectrode arrays. Cells 12 (9), 1270. 10.3390/cells12091270 37174670 PMC10177384 · DOI · Paper page
  57. Hoelting L. Klima S. Karreman C. Grinberg M. Meisig J. Henry M. (2016). Stem cell-derived immature human dorsal root ganglia neurons to identify peripheral neurotoxicants. Stem Cells Transl. Med. 5 (4), 476– 487. 10.5966/SCTM.2015-0108 26933043 PMC4798731 · DOI
  58. Hollander J. A. Cory-Slechta D. A. Jacka F. N. Szabo S. T. Guilarte T. R. Bilbo S. D. (2020). Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease. Neuropsychopharmacology 45 (7), 1086– 1096. 10.1038/s41386-020-0648-5 32109936 PMC7234981 · DOI
  59. Holzer A. K. Karreman C. Suciu I. Furmanowsky L. S. Wohlfarth H. Loser D. (2022). Generation of human nociceptor-enriched sensory neurons for the study of pain-related dysfunctions. Stem Cells Transl. Med. 11 (7), 727– 741. 10.1093/STCLTM/SZAC031 35689659 PMC9299516 · DOI
  60. Hooijmans C. R. Leenaars M. Ritskes-Hoitinga M. (2010). A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three rs, and to make systematic reviews more feasible. Altern. Lab. Anim. 38 (2), 167– 182. 10.1177/026119291003800208 20507187 · DOI
  61. Horzmann K. A. Freeman J. L. (2016). Zebrafish get connected: investigating neurotransmission targets and alterations in chemical toxicity. Toxics 4 (3), 19. 10.3390/TOXICS4030019 28730152 PMC5515482 · DOI
  62. Howe K. Clark M. D. Torroja C. F. Torrance J. Berthelot C. Muffato M. (2013). The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498– 503. 10.1038/nature12111 23594743 PMC3703927 · DOI · Paper page
  63. Imayoshi I. Shimojo H. Sakamoto M. Ohtsuka T. Kageyama R. (2013). Genetic visualization of Notch signaling in mammalian neurogenesis. Cell. Mol. Life Sci. 70, 2045– 2057. 10.1007/s00018-012-1151-x 22971775 PMC3663255 · DOI
  64. Jacobson M. H. Ghassabian A. Gore A. C. Trasande L. (2022). Exposure to environmental chemicals and perinatal psychopathology. Biochem. Pharmacol. 195 (January), 114835. 10.1016/J.BCP.2021.114835 34774531 PMC8712457 · DOI
  65. Jarema K. A. Hunter D. L. Hill B. N. Olin J. K. Britton K. N. Waalkes M. R. (2022). Developmental neurotoxicity and behavioral screening in larval zebrafish with a comparison to other published results. Toxics 10 (5), 256. 10.3390/toxics10050256 35622669 PMC9145655 · DOI
  66. Kalueff A. V. Gebhardt M. Stewart A. M. Cachat J. M. Brimmer M. Chawla J. S. (2013). Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10 (1), 70– 86. Https://Home.Liebertpub.Com/Zeb. 10.1089/ZEB.2012.0861 23590400 PMC3629777 · DOI
  67. Kang Du S. Yang Y. R. Lee C. Kim S. B. Ryu S.Ho Suh P. G. (2016). Roles of phosphoinositide-specific phospholipase Cγ1 in brain development. Adv. Biol. Regul. 60 (January), 167– 173. 10.1016/J.JBIOR.2015.10.002 26588873 · DOI
  68. Kavlock R. J. Bahadori T. Barton-Maclaren T. S. Gwinn M. R. Rasenberg M. Thomas R. S. (2018). Accelerating the pace of chemical risk assessment. Chem. Res. Toxicol. 31 (5), 287– 290. 10.1021/ACS.CHEMRESTOX.7B00339 29600706 PMC6666390 · DOI
  69. Kettleborough R. N. W. Busch-Nentwich E. M. Harvey S. A. Dooley C. M. De Bruijn E. Van Eeden F. (2013). A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496 (7446), 494– 497. 10.1038/NATURE11992 23594742 PMC3743023 · DOI
  70. Khelfaoui H. Harkati D. Saleh B. A. (2021). Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2. J. Biomol. Struct. Dyn. 39 (18), 7246– 7262. 10.1080/07391102.2020.1803967 32752951 PMC7484571 · DOI
  71. Klima S. Brüll M. Spreng A. S. Suciu I. Falt T. Schwamborn J. C. (2021). A human stem cell-derived test system for agents modifying neuronal N-Methyl-D-Aspartate-Type glutamate receptor Ca 2+-signalling. Archives Toxicol. 95 (5), 1703– 1722. 10.1007/S00204-021-03024-0 PMC8113295 33713149 · DOI
  72. Klose J. Tigges J. Masjosthusmann S. Schmuck K. Bendt F. Hübenthal U. (2021). TBBPA targets converging key events of human oligodendrocyte development resulting in two novel AOPs. Altex 38 (2), 215– 234. 10.14573/altex.2007201 33099281 · DOI
  73. Klüver N. Vogs C. Altenburger R. Escher B. I. Scholz S. (2016). Development of a general baseline toxicity QSAR model for the fish embryo acute toxicity test. Chemosphere 164 (December), 164– 173. 10.1016/J.CHEMOSPHERE.2016.08.079 27588575 · DOI
  74. Knoll-Gellida A. Dubrana L. E. Bourcier L. M. eo Merc Th Gruel E. Soares M. (2021). Hyperactivity and seizure induced by tricresyl phosphate are isomer specific and not linked to phenyl valerate-neuropathy target esterase activity inhibition in zebrafish. Toxicol. Sci. 180 (1), 160– 174. 10.1093/toxsci/kfab006 33483753 · DOI
  75. Koch K. Bartmann K. Hartmann J. Kapr J. Pahl M. Fritsche E. (2022). Scientific validation of human neurosphere assays for developmental neurotoxicity evaluation. Front. Press 0, 816370– 816438. 10.3389/FTOX.2022.816370 PMC8915868 35295221 · DOI · Paper page
  76. Krug A. K. Balmer N. V. Matt F. Schönenberger F. Merhof D. Leist M. (2013). Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Archives Toxicol. 87 (12), 2215– 2231. 10.1007/s00204-013-1072-y 23670202 · DOI
  77. Krzykwa J. C. Saeid A. Sellin Jeffries M. K. (2019). Identifying sublethal endpoints for evaluating neurotoxic compounds utilizing the fish embryo toxicity test. Ecotoxicol. Environ. Saf. 170 (April), 521– 529. 10.1016/J.ECOENV.2018.11.118 30557710 · DOI
  78. Lauvås A. J. Lislien M. Andreas Holme J. Dirven H. Paulsen E. Alm I. M. (2022). Developmental neurotoxicity of acrylamide and its metabolite glycidamide in a human mixed culture of neurons and astrocytes undergoing differentiation in concentrations relevant for human exposure. Neurotoxicology 92, 33– 48. 10.1016/j.neuro.2022.07.001 35835329 · DOI
  79. Lee Da Y. (2015). Roles of MTOR signaling in brain development. Exp. Neurobiol. 24 (3), 177– 185. 10.5607/EN.2015.24.3.177 26412966 PMC4580744 · DOI
  80. Lee J. Escher B. I. Scholz S. Schlichting R. (2022a). Inhibition of neurite outgrowth and enhanced effects compared to baseline toxicity in SH-SY5Y cells. Archives Toxicol. 96 (4), 1039– 1053. 10.1007/s00204-022-03237-x PMC8921145 35182163 · DOI
  81. Lee J. Schlichting R. König M. Scholz S. Krauss M. Escher B. I. (2022b). Monitoring mixture effects of neurotoxicants in surface water and wastewater treatment plant effluents with neurite outgrowth inhibition in SH-SY5Y cells. Am. Chem. Soc. 2, 523– 535. 10.1021/acsenvironau.2c00026 PMC10125335 37101724 · DOI
  82. Leist M. Ahmed G. Graepel R. Marchan R. Hassan R. Hougaard Bennekou S. (2017). Adverse outcome pathways: opportunities, limitations and open questions. Archives Toxicol. 91 (11), 3477– 3505. 10.1007/S00204-017-2045-3 29051992 · DOI · Paper page
  83. López-Espíndola D. Morales-Bastos C. Grijota-Martínez C. Liao X. H. Lev D. Sugo E. (2014). Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. J. Clin. Endocrinol. Metabolism 99 (12), E2799– E2804. 10.1210/jc.2014-2162 PMC4255116 25222753 · DOI · Paper page
  84. Loser D. Hinojosa M. G. Blum J. Schaefer J. Brüll M. Johansson Y. (2021). Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons. Archives Toxicol. 95 (6), 2081– 2107. 10.1007/S00204-021-03031-1 PMC8166715 33778899 · DOI
  85. Louit A. Beaudet M. J. Pépin R. Berthod F. (2023). Differentiation of human induced pluripotent stem cells into mature and myelinating Schwann cells. Https//Home.Liebertpub.Com/Tec 29 (4), 134– 143. 10.1089/TEN.TEC.2022.0186 36792923 · DOI
  86. Makris S. L. Raffaele K. Allen S. Bowers W. J. Hass U. Alleva E. (2009). A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ. Health Perspect. 117 (1), 17– 25. 10.1289/EHP.11447 19165382 PMC2627860 · DOI
  87. Marx-Stoelting P. Rivière G. Luijten · M. Aiello-Holden · K. Bandow · N. Baken · K. (2023). A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe. Arch. Toxicol. 97, 893– 908. 10.1007/s00204-022-03435-7 36645448 PMC9968685 · DOI
  88. Masjosthusmann S. Barenys M. El‐Gamal M. Geerts L. Gerosa L. Gorreja A. (2018). Literature review and appraisal on alternative neurotoxicity testing methods. EFSA Support. Publ. 15 (4), 1– 108. 10.2903/sp.efsa.2018.en-1410 · DOI
  89. Masjosthusmann S. Blum J. Bartmann K. Dolde X. Holzer A.-K. Stürzl L.-C. (2020). Establishment of an a priori protocol for the implementation and interpretation of an in‐vitro testing battery for the assessment of developmental neurotoxicity. EFSA Supporting Publication. Wiley. 10.2903/sp.efsa.2020.en-1938 · DOI · Paper page
  90. Muller Q. Beaudet M. J. De Serres-Bérard T. Bellenfant S. Vincent F. Berthod F. (2018). Development of an innervated tissue-engineered skin with human sensory neurons and Schwann cells differentiated from IPS cells. Acta Biomater. 82 (December), 93– 101. 10.1016/J.ACTBIO.2018.10.011 30316025 · DOI
  91. Nimtz L. Klose J. Masjosthusmann S. Barenys M. Fritsche E. (2019). The neurosphere assay as an in vitro method for developmental neurotoxicity (DNT) evaluation. Eval. Neuromethods 145, 141– 168. 10.1007/978-1-4939-9228-7_8 · DOI
  92. Noyes P. D. Haggard D. E. Gonnerman G. D. Tanguay R. L. (2015). Advanced morphological — behavioral test platform reveals neurodevelopmental defects in embryonic zebrafish exposed to comprehensive suite of halogenated and organophosphate flame retardants. Toxicol. Sci. 145 (1), 177– 195. 10.1093/TOXSCI/KFV044 25711236 PMC4408965 · DOI
  93. Nyffeler J. Dolde X. Krebs A. Pinto-Gil K. Pastor M. Behl M. (2017). Combination of multiple neural crest migration assays to identify environmental toxicants from a proof-of-concept chemical library. Archives Toxicol. 91 (11), 3613– 3632. 10.1007/s00204-017-1977-y PMC9730781 28477266 · DOI
  94. Ockleford C. Adriaanse P. Berny P. Brock T. Duquesne S. Grilli S. (2017). Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson’s disease and childhood leukaemia. EFSA J. 15 (3), e04691. 10.2903/J.EFSA.2017.4691 32625422 PMC7233269 · DOI
  95. OECD. (1995a). “ Test No. 418: delayed neurotoxicity of organophosphorus substances following acute exposure.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070905-en · DOI
  96. OECD. (1995b). “ Test No. 419: delayed neurotoxicity of organophosphorus substances: 28-day repeated dose study.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070929-en · DOI
  97. OECD. (1997). “ Test No. 424: neurotoxicity study in rodents.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264071025-en · DOI
  98. OECD. (2002a). “ Test No. 420: acute oral toxicity - fixed dose procedure.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070943-en · DOI
  99. OECD. (2002b). “ Test No. 423: acute oral toxicity - acute toxic class method.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264071001-en · DOI
  100. OECD. 2007. “ Test No. 426: developmental neurotoxicity study.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264067394-en · DOI · Paper page
  101. OECD. 2008b. “ Test No. 407: repeated dose 28-day oral toxicity study in rodents.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070684-en · DOI
  102. OECD. (2009). “ Test No. 403: acute inhalation toxicity.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070608-en · DOI
  103. OECD. (2017). “ Test No. 402: acute dermal toxicity.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070585-en · DOI
  104. OECD. (2018a). “ Test No. 408: repeated dose 90-day oral toxicity study in rodents.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264070707-en · DOI
  105. OECD. (2018b). Test No. 443: extended one-generation reproductive toxicity study. 10.1787/20745788 · DOI
  106. OECD. (2022). “ Test No. 425: acute oral toxicity - up-and-down procedure.” In. OECD guidelines for the testing of chemicals, Section 4. OECD. 10.1787/9789264071049-en · DOI
  107. Pallocca G. Moné M. J. Kamp H. Luijten M. van de Water B. Leist M. (2022). Next-generation risk assessment of chemicals - rolling out a human-centric testing strategy to drive 3R implementation: the RISK-hunt3r project perspective. Altex 39 (3), 419– 426. 10.14573/ALTEX.2204051 35404467 · DOI
  108. Paparella M. Bennekou S. H. Bal-Price A. (2020). An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches. Reprod. Toxicol. 96 (September), 327– 336. 10.1016/J.REPROTOX.2020.08.002 32781019 · DOI
  109. Pitzer E. M. Shafer T. J. Herr D. W. (2023). Identification of Neurotoxicology (NT)/Developmental Neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays. Neurotoxicology 99 (December), 184– 194. 10.1016/J.NEURO.2023.10.007 37866692 PMC12117389 · DOI
  110. Raj B. Wagner D. E. McKenna A. Pandey S. Klein A. M. Shendure J. (2018). Simultaneous single-cell profiling of lineages and cell types in the vertebrate brain. Nat. Biotechnol. 36 (5), 442– 450. 10.1038/nbt.4103 29608178 PMC5938111 · DOI
  111. Rice D. Barone S. (2000). Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl. 3), 511– 533. 10.1289/ehp.00108s3511 10852851 PMC1637807 · DOI · Paper page
  112. Rietdijk J. Aggarwal T. Georgieva P. Lapins M. Carreras-Puigvert J. Spjuth O. (2022). Morphological profiling of environmental chemicals enables efficient and untargeted exploration of combination effects, Sci. Total Environ. 832, 155058. 10.1016/j.scitotenv.2022.155058 35390365 · DOI
  113. Rokoff L. B. Shoaff J. R. Coull B. A. Enlow M. B. Bellinger D. C. Korrick S. A. (2022). Prenatal exposure to a mixture of organochlorines and metals and internalizing symptoms in childhood and adolescence. Environ. Res. 208 (May), 112701. 10.1016/J.ENVRES.2022.112701 35016863 PMC8917058 · DOI
  114. Sachana M. Bal-Price A. Crofton K. M. Bennekou S. H. Shafer T. J. Behl M. (2019). International regulatory and scientific effort for improved developmental neurotoxicity testing. Toxicol. Sci. 167 (1), 45– 57. 10.1093/toxsci/kfy211 30476307 · DOI
  115. Saili K. S. Todd J. Z. Schwab A. J. Silvin A. Baker N. C. Sidney Hunter E. (2017). Blood-brain barrier development: systems modeling and predictive Toxicology. Birth Defects Res. 109 (20), 1680– 1710. 10.1002/BDR2.1180 29251840 PMC6476421 · DOI
  116. Sakai C. Ijaz S. Hoffman E. J. Grünblatt E. Carl M. Lange M. (2018). Zebrafish models of neurodevelopmental disorders: past, present, and future. Front. Mol. Neurosci. 11, 294. 10.3389/fnmol.2018.00294 30210288 PMC6123572 · DOI
  117. Sato-Maeda M. Tawarayama H. Obinata M. Kuwada J. Y. Shoji W. (2006). Sema3a1 guides spinal motor axons in a cell- and stage-specific manner in zebrafish. Dev. Camb. Engl. 133 (5), 937– 947. 10.1242/DEV.02268 16452100 · DOI
  118. Schenke M. Schjeide B. M. Püschel G. P. Seeger B. (2020). Analysis of motor neurons differentiated from human induced pluripotent stem cells for the use in cell-based botulinum neurotoxin activity assays. Toxins 12 (5), 276. 10.3390/TOXINS12050276 32344847 PMC7291138 · DOI
  119. Schmeisser S. Miccoli A. von Bergen M. Berggren E. Braeuning A. Busch W. (2023). New approach methodologies in human regulatory Toxicology – not if, but how and when. Environ. Int. 178 (March), 108082. 10.1016/J.ENVINT.2023.108082 37422975 PMC10858683 · DOI
  120. Schmidt B. Z. Lehmann M. Gutbier S. Nembo E. Noel S. Smirnova L. (2017). In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Archives Toxicol. 91 (1), 1– 33. 10.1007/S00204-016-1805-9 27492622 · DOI
  121. Schmidt R. Strähle U. Scholpp S. (2013). Neurogenesis in zebrafish - from embryo to adult. Neural Dev. 8 (1), 3– 13. 10.1186/1749-8104-8-3 23433260 PMC3598338 · DOI
  122. Schmuck M. R. Temme T. Dach K. Boer D. de Barenys M. Bendt F. (2017). Omnisphero: a high-content image analysis (hca) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro. Archives Toxicol. 91 (4), 2017– 2028. 10.1007/s00204-016-1852-2 27722930 · DOI
  123. Semple B. D. Blomgren K. Gimlin K. Ferriero D. M. Noble-Haeusslein L. J. (2013). Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 106-107, 1– 16. 0 (July). 10.1016/J.PNEUROBIO.2013.04.001 23583307 PMC3737272 · DOI · Paper page
  124. Shafer T. J. (2019). Application of microelectrode array approaches to neurotoxicity testing and screening. Adv. Neurobiol. 22, 275– 297. 10.1007/978-3-030-11135-9_12 31073941 · DOI
  125. Sheets L. P. Li A. A. Minnema D. J. Collier R. H. Creek M. R. Peffer R. C. (2016). A critical review of neonicotinoid insecticides for developmental neurotoxicity. Crit. Rev. Toxicol. 46 (2), 153– 190. 10.3109/10408444.2015.1090948 26513508 PMC4732412 · DOI
  126. Smirnova L. Hogberg H. T. Leist M. Hartung T. (2014). Food for thought.: developmental neurotoxicity - challenges in the 21st century and in vitro opportunities. Altex 31 (2), 129– 156. 10.14573/ALTEX.1403271 24687333 PMC4778747 · DOI
  127. Sobanska M. Scholz S. Nyman A. M. Cesnaitis R. Alonso S. G. Klüver N. (2018). Applicability of the fish embryo acute toxicity (FET) test (OECD 236) in the regulatory context of registration, evaluation, authorisation, and restriction of chemicals (REACH). Environ. Toxicol. Chem. 37 (3), 657– 670. 10.1002/ETC.4055 29226368 · DOI
  128. Spalding K. L. Bergmann O. Alkass K. Bernard S. Salehpour M. Huttner H. B. (2013). Dynamics of hippocampal neurogenesis in adult humans. Cell 153 (6), 1219– 1227. 10.1016/j.cell.2013.05.002 23746839 PMC4394608 · DOI · Paper page
  129. Spencer P. S. Lein P. J. (2014). “ Neurotoxicity,” in Encyclopedia of Toxicology (January, Third Edition), 489– 500. 10.1016/B978-0-12-386454-3.00169-X · DOI
  130. Spînu N. Cronin M. T. D. Lao J. Bal-Price A. Campia I. Enoch S. J. (2021). Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network. Comput. Toxicol., 100206. 10.1016/j.comtox.2021.100206 PMC8857173 35211661 · DOI
  131. Spreng A. S. Brüll M. Leisner H. Suciu I. Leist M. (2022). Distinct and dynamic transcriptome adaptations of IPSC-generated astrocytes after cytokine stimulation. Cells 11 (17), 2644. 10.3390/CELLS11172644 36078052 PMC9455058 · DOI
  132. Strähle U. Scholz S. Geisler R. Greiner P. Hollert H. Rastegar S. (2012). Zebrafish embryos as an alternative to animal experiments—a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 33 (2), 128– 132. 10.1016/J.REPROTOX.2011.06.121 21726626 · DOI
  133. Stucki A. O. Barton-Maclaren T. S. Bhuller Y. Henriquez J. E. Henry T. R. Hirn C. (2022). Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health. Front. Toxicol. 4, 964553. 10.3389/FTOX.2022.964553 36119357 PMC9475191 · DOI
  134. Suciu I. Pamies D. Peruzzo R. Wirtz P. H. Smirnova L. Pallocca G. (2023). G × E interactions as a basis for toxicological uncertainty. Archives Toxicol. 97 (7), 2035– 2049. 10.1007/S00204-023-03500-9 PMC10256652 37258688 · DOI
  135. Tanner C. M. Goldman S. M. Webster Ross G. Grate S. J. (2014). The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. Alzheimer’s Dementia 10 (3 Suppl. L), S213– S225. 10.1016/J.JALZ.2014.04.014 24924672 · DOI
  136. Terron A. Bennekou S. H. (2018). Towards a regulatory use of alternative developmental neurotoxicity testing (DNT). Toxicol. Appl. Pharmacol. 354 (December 2017), 19– 23. 10.1016/j.taap.2018.02.002 29454059 · DOI
  137. Tian G. Harrison P. J. Sreenivasan A. P. Carreras-Puigvert J. Spjuth O. (2023). Combining molecular and cell painting image data for mechanism of action prediction. Artif. Intell. Life Sci. 3 (December), 100060. 10.1016/J.AILSCI.2023.100060 · DOI
  138. Tsuji R. Crofton K. M. (2012). Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation. Congenit. Anomalies 52 (3), 122– 128. 10.1111/J.1741-4520.2012.00374.X 22925212 · DOI
  139. Vinken M. Benfenati E. Busquet F. Castell J. Clevert D.-A. de Kok T. M. (2021). Safer chemicals using less animals: kick-off of the European ONTOX project. Toxicology 458 (June), 152846. 10.1016/J.TOX.2021.152846 34216698 · DOI
  140. Wang Z. Walker G. W. Muir D. C. G. Nagatani-Yoshida K. (2020). Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ. Sci. Technol. 54 (5), 2575– 2584. 10.1021/acs.est.9b06379 31968937 · DOI · Paper page

Cited by

Sorted by citations

Authors
Tal, T., Myhre, O., Fritsche, E., Rüegg, J., Craenen, K., Aiello-Holden, K., Agrillo, C., Babin, P. J., Escher, B. I., Dirven, H., Hellsten, K., Dolva, K., Hessel, E., Heusinkveld, H. J., Hadzhiev, Y., Hurem, S., Jagiello, K., Judzinska, B., Klüver, N., Knoll-Gellida, A., Kühne, B. A., Leist, M., Lislien, M., Lyche, J. L., Müller, F., Colbourne, J. K., Neuhaus, W., Pallocca, G., Seeger, B., Scharkin, I., Scholz, S., Spjuth, O., Torres-Ruiz, M., & Bartmann, K.
Venue
Frontiers in Toxicology
Publisher
Frontiers Media SA
Published
2024-04-26
Volume
6
ISSN
2673-3080
DOI
10.3389/ftox.2024.1359507
PMC
PMC11089904
Cited by
58
References
10
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Helmholtz-Gemeinschaft

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review